How we evaluate treatment evidence
Our published clinical content is designed to separate research conclusions, clinician interpretation and patient preferences.
Evidence hierarchy
Guidelines and systematic reviews are prioritised where suitable, followed by randomised trials and robust observational evidence. Study design alone does not guarantee quality: applicability, bias, outcomes, absolute benefits, uncertainty and harms matter.
Balanced interpretation
Benefits should be reported alongside null results and harms. Research on one diagnosis, modality or body region must not be extrapolated to all musculoskeletal problems.
Ultrasound standards
Review workflow
Each clinical page should record reviewer, qualification, date, next review and source register. Clinical content is reviewed and updated as relevant guidance develops.
Research transparency
We do not claim to have completed 400 study appraisals. The research register grows only when original sources are inspected and verified.
References
- NICE (2022) Osteoarthritis in over 16s: diagnosis and management. NICE guideline NG226. Read official guidance
- NICE (2016, amended 2026) Low back pain and sciatica in over 16s: assessment and management. NICE guideline NG59. Read official guidance
- Google Search Central (2026) Creating helpful, reliable, people-first content. Read official guidance
